About Endoc

Shenzhen Endoc Medical Co., Ltd., located in the Shenzhen PingShan National High-Tech Bioindustry Base, has been dedicated to the development, production, and sales of continuous glucose monitoring devices and insulin pumps since its establishment in 2018, with the goal of creating an artificial pancreas system designed for the Chinese population. As a national high-tech enterprise, Endoc Medical is also among the few companies in China that have mastered the three core technologies in the field of diabetes care: continuous glucose monitoring systems (CGM), continuous subcutaneous insulin infusion (CSII) pumps, and control algorithms.